Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/20161
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, H | - |
dc.contributor.author | Kim, J | - |
dc.contributor.author | Kang, YA | - |
dc.contributor.author | Kim, DR | - |
dc.contributor.author | Sim, B | - |
dc.contributor.author | Zelmer, A | - |
dc.contributor.author | Fletcher, HA | - |
dc.contributor.author | Dockrell, HM | - |
dc.contributor.author | Smith, SG | - |
dc.contributor.author | Cho, S-N | - |
dc.date.accessioned | 2020-02-03T15:11:22Z | - |
dc.date.available | 2020-02-03T15:11:22Z | - |
dc.date.issued | 2019-04-26 | - |
dc.identifier.citation | Frontiers in Immunology, 10 | en_US |
dc.identifier.issn | http://dx.doi.org/10.3389/fimmu.2019.00896 | - |
dc.identifier.issn | 1664-3224 | - |
dc.identifier.issn | http://dx.doi.org/10.3389/fimmu.2019.00896 | - |
dc.identifier.issn | 1664-3224 | - |
dc.identifier.issn | http://dx.doi.org/10.3389/fimmu.2019.00896 | - |
dc.identifier.issn | 1664-3224 | - |
dc.identifier.uri | http://bura.brunel.ac.uk/handle/2438/20161 | - |
dc.description.abstract | It is important to understand the ability to inhibit mycobacterial growth in healthy adults who would have been Bacillus Calmette-Guérin (BCG) vaccinated in childhood as this group will be the potential target population for novel booster TB vaccine trials. In this study we investigated not only the long-term immunity induced by childhood BCG vaccination but also protective immunity in terms of the ability to inhibit mycobacterial growth in those who were BCG vaccinated in childhood, with evidence of recent or remote TB infection. | en_US |
dc.description.sponsorship | This study was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) founded by the Ministry of Science, ICT and Future Planning (NRF-2015K1A3A7A03073714) and from the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) founded by the Ministry for Health, Welfare, and Family Affairs, Republic of Korea (HI14C1324). LSHTM and ITRC are partners in a grant under the MRC-KHIDI UK-Korea Partnering Award scheme awarded to HL and SS with Grant No. HI17C0324 and MC_PC_17109 in TBVAC2020 supported by the European Commission under the H2020 program, with Grant No. 643381; the ITRC group was funded by a Grant (NRF-2015K1A3A7A03073714). | en_US |
dc.language.iso | en | en_US |
dc.publisher | Frontiers Media SA | en_US |
dc.subject | mycobacterial growth inhibition | en_US |
dc.subject | correlates | en_US |
dc.subject | vaccine | en_US |
dc.subject | tuberculosis | en_US |
dc.subject | latent tuberculosis infection | en_US |
dc.title | In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection | en_US |
dc.type | Article | en_US |
dc.identifier.doi | http://dx.doi.org/10.3389/fimmu.2019.00896 | - |
dc.relation.isPartOf | Frontiers in Immunology | - |
pubs.publication-status | Published online | - |
pubs.volume | 10 | - |
dc.identifier.eissn | 1664-3224 | - |
Appears in Collections: | Publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Fulltext.pdf | 1.57 MB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.